title: Absent immunoglobulins in HIV-related Burkitt lymphoma/leukaemia.
authors.forename: Akihiko
authors.initials: A
authors.lastname: Shimomura
authors.forename: Marie von
authors.initials: Mv
authors.lastname: Lilienfeld-Toal
authors.forename: Zeynep
authors.initials: Z
authors.lastname: Balta
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Schroers
authors.forename: Ingo G H
authors.initials: IG
authors.lastname: Schmidt-Wolf
authors.forename: Reinhard
authors.initials: R
authors.lastname: Büttner
authors.forename: Alexander von
authors.initials: Av
authors.lastname: Rücker
authors.forename: Ines
authors.initials: I
authors.lastname: Gütgemann
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D023241:Antiretroviral Therapy, Highly Active; D001402:B-Lymphocytes; D001772:Blood Cell Count; D001853:Bone Marrow / Q000378:metabolism / Q000473:pathology; D002051:Burkitt Lymphoma / Q000097:blood* / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D015658:HIV Infections / Q000097:blood* / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D007136:Immunoglobulins / Q000097:blood*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D013713:Teniposide / Q000008:administration & dosage
chemical_list: D007136:Immunoglobulins; D003561:Cytarabine; D003907:Dexamethasone; D003520:Cyclophosphamide; D013713:Teniposide; D011239:Prednisolone; D007069:Ifosfamide; D008727:Methotrexate